At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Ablation Efficacy of Contact Side Firing Fiber in Predefined Settings for Treating BPH
In Brief
A clinical study evaluating Lumenis Pulse P120H and Xpeeda side firing fiber for Treatment of Benign Prostatic Hyperplasia. Completed, enrolled 20 participants across 1 site.
Detailed Summary
Twenty (20) subjects presenting with a hyperplasia enlarged prostate and candidates for surgery will undergo a single treatment for ablation of the prostate using the study device. Follow up visits are scheduled for the day of release from the hospital and at 1 and 3 months post procedure. The primary objective of this study is to explore Vaporization efficacy and safety when treating BPH (Benign prostatic hyperplasia) with the contact side firing fiber with recommended settings.